source
- Novartis climbs on upbeat drug sales as key readouts loomA return to quarterly sales growth boosted shares higher on Tuesday, though a handful of coming study results will have a bigger impact on the company’s long-term outlook.BioPharma Dive · 8d ago↗ source
- STAT+: Advocates say federal funding is being cut from groups fighting HIVThe administration is shifting some funding to states, but community groups are set to lose out.STAT · 8d ago↗ source
- Crystalys mines $130M series B to push gout drug through phase 3Crystalys Therapeutics has raised $130 million in series B financing to advance the development of its gout drug dotinurad and prepare for a potential commercial launch.Fierce Biotech · 8d ago↗ source